Ask AI
ProCE Banner Series

Game On! Beat the Buzzer Competitive Challenge to Optimize Radioligand Therapy in Metastatic APMN/S Prostate Cancer

Join us for this 1-hour symposium to gain insights from experts on the integration of radioligand therapy into mHSPC management. Key discussion topics will include identification of candidate patients and interpretation of PSMA PET/CT findings, supporting evidence and sequencing of radioligand therapy in the current treatment landscape, and coordinating multidisciplinary workflows.

In conjunction with the SUO Annual Meeting

  AAPA
  | ACPE
  | AMA
  | ANCC
Who Should Attend

This activity is intended for urologists, nurses, pharmacists, physician associates, and other healthcare professionals who care for patients with prostate cancer.

All Events

Game On! Beat the Buzzer Competitive Challenge to Optimize Radioligand Therapy in Metastatic APMN/S Prostate Cancer

Upcoming Events

December

01

2026

7:00 AM - 8:30 AM Pacific Time (PT)

In-person

Hilton San Diego Bayfront, 1 Park Blvd., San Diego, California 92101

7:30 AM - 8:30 AM Pacific Time (PT)

Virtual

Topics

Prostate cancer

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners’ knowledge, confidence, and competence in applying evidence-based radioligand therapy within PSMA-guided, multidisciplinary care pathways, with a focus on treatment sequencing, patient selection, safety monitoring, and coordinated care to improve outcomes for patients with prostate cancer.

Target Audience
This activity is intended for urologists, nurses, pharmacists, physician associates, and other healthcare professionals who care for patients with prostate cancer.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Interpret current and emerging clinical evidence supporting the role of radioligand therapy across treatment settings in mHSPC

  • Identify patients appropriate for radioligand therapy evaluation or clinical trial referral based on PSMA PET/CT findings

  • Select evidence-based sequencing strategies that appropriately position radioligand therapy relative to ADT, ARPIs, chemotherapy, and other treatments

  • Plan appropriate monitoring strategies to mitigate treatment-related adverse events associated with radiopharmaceutical therapies

  • Counsel eligible patients on available clinical trials and emerging investigational approaches involving radioligand and combination therapies in mHSPC

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

Clinical Care Options, LLC dba Decera Clinical Education designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-26-592-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification

Title: A blue and black sign with white textDescription automatically generated

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.0 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through Decera Clinical Education’s Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Decera Clinical Education permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

IPCE Credit Designation

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/657115052be04.jpg

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191